CHIASMA
Chiasma applies its proprietary technology to approved drugs, which not only enables their being switched from injectable to oral, but importantly can result in new indications and/or enhanced absorption. The Company's Transient Permeability Enhancer technology promotes the delivery of drugs to the GI wall and from there to the liver. It is applicable to macromolecules that to-date can be administered only by injection. TPE can be utilized also with small molecules that are already orally available but are poorly absorbed.
CHIASMA
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2001-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.chiasma.com
Total Employee:
51+
Status:
Active
Contact:
972 2 571 5885
Email Addresses:
[email protected]
Total Funding:
246 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 IIS Pound Sterling Microsoft ASP.NET 4.0 Microsoft Azure ASP.NET Ajax
Similar Organizations
Boston Immune Technologies & Therapeutics
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
DiaMedica
DiaMedica is a biopharmaceutical company focused on developing innovative treatments for stroke.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Manus Bio
Manus Bio makes nature accessible and affordable for a growing society.
Relypsa
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Renovis
Renovis,is a biopharmaceutical company developing drugs to treat neurological diseases and disorders.
SAJE Pharma
SAJE Pharma is a bio-pharmaceutical company developing therapeutic agents for respiratory diseases.
SpringWorks Therapeutics
SpringWorks Therapeutics is a biopharmaceutical company focused on developing medicines for patients with severe rare diseases and cancer.
Thesan Pharmaceuticals
Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.
Transition Therapeutics
Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.
Triana Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Poalim Equity
Poalim Equity investment in Post-IPO Equity - Chiasma
Blue Chip Venture Company
Blue Chip Venture Company investment in Series E - Chiasma
Abingworth
Abingworth investment in Series E - Chiasma
Sofinnova Investments
Sofinnova Investments investment in Series E - Chiasma
Rock Springs Capital
Rock Springs Capital investment in Series E - Chiasma
ARCH Venture Partners
ARCH Venture Partners investment in Series E - Chiasma
F2 Ventures
F2 Ventures investment in Series E - Chiasma
MPM Capital
MPM Capital investment in Series E - Chiasma
7 Health Ventures
7 Health Ventures investment in Series E - Chiasma
Abingworth
Abingworth investment in Series D - Chiasma
Official Site Inspections
http://www.chiasma.com Semrush global rank: 7.45 M Semrush visits lastest month: 492
- Host name: 172.67.153.113
- IP address: 172.67.153.113
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
